1. Home
  2. AMBO vs INTS Comparison

AMBO vs INTS Comparison

Compare AMBO & INTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMBO
  • INTS
  • Stock Information
  • Founded
  • AMBO 2000
  • INTS 2012
  • Country
  • AMBO United States
  • INTS United States
  • Employees
  • AMBO N/A
  • INTS N/A
  • Industry
  • AMBO Other Consumer Services
  • INTS Biotechnology: Pharmaceutical Preparations
  • Sector
  • AMBO Real Estate
  • INTS Health Care
  • Exchange
  • AMBO Nasdaq
  • INTS Nasdaq
  • Market Cap
  • AMBO 12.7M
  • INTS 12.2M
  • IPO Year
  • AMBO 2010
  • INTS 2023
  • Fundamental
  • Price
  • AMBO $3.89
  • INTS $0.44
  • Analyst Decision
  • AMBO
  • INTS Strong Buy
  • Analyst Count
  • AMBO 0
  • INTS 4
  • Target Price
  • AMBO N/A
  • INTS $4.50
  • AVG Volume (30 Days)
  • AMBO 22.3K
  • INTS 85.2M
  • Earning Date
  • AMBO 08-05-2025
  • INTS 11-06-2025
  • Dividend Yield
  • AMBO N/A
  • INTS N/A
  • EPS Growth
  • AMBO N/A
  • INTS N/A
  • EPS
  • AMBO 0.69
  • INTS N/A
  • Revenue
  • AMBO $9,699,000.00
  • INTS N/A
  • Revenue This Year
  • AMBO N/A
  • INTS N/A
  • Revenue Next Year
  • AMBO N/A
  • INTS N/A
  • P/E Ratio
  • AMBO $6.04
  • INTS N/A
  • Revenue Growth
  • AMBO 23.73
  • INTS N/A
  • 52 Week Low
  • AMBO $1.32
  • INTS $0.19
  • 52 Week High
  • AMBO $6.75
  • INTS $3.30
  • Technical
  • Relative Strength Index (RSI)
  • AMBO 53.30
  • INTS 50.66
  • Support Level
  • AMBO $3.50
  • INTS $0.38
  • Resistance Level
  • AMBO $4.35
  • INTS $0.57
  • Average True Range (ATR)
  • AMBO 0.45
  • INTS 0.18
  • MACD
  • AMBO 0.01
  • INTS -0.01
  • Stochastic Oscillator
  • AMBO 72.12
  • INTS 13.59

About AMBO Ambow Education Holding Ltd.

Ambow Education Holding Ltd is an AI-driven technology educational company. Along with its subsidiaries, the company is developing a new HybriU AI Digital Education Solution that transforms the educational environment, bridging the gap between traditional methods and the future of digital learning. The solution combines sophisticated software and hardware to create an AI-powered digital and hybrid classroom, designed to enhance educational delivery and engagement. In addition, the group offers high-quality, individualized, and dynamic career education services and products through the operation of its for-profit colleges. Substantially the majority of the group's revenues are derived from the United States, based on the geographical locations where services are provided to customers.

About INTS Intensity Therapeutics Inc.

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.

Share on Social Networks: